Review summarizes pathophysiology and screening approaches for cystic fibrosis related diabetes, suggesting new strategies for improvement.
Cystic Fibrosis Related Diabetes (CFRD) is a well-recognized and increasingly prevalent complication of cystic fibrosis (CF), most frequently developing in adolescence and adulthood. CFRD is associated with pulmonary function decline, poor nutritional status, and increased infection risk, and contributes to increased morbidity and mortality. The objective of this review is 1) to provide a summary of CFRD pathophysiology, highlighting the spectrum of glycemic abnormalities preceding development of CFRD, and 2) to review CFRD screening guidelines, including a narrative review of the current evidence for different CFRD screening approaches. We also review challenges to screening and important considerations in the setting of novel CF therapeutics and increasing longevity in this population.
No takes yet. Share an insight, caveat, or question.
Apsan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: